Skip to main content

This job has expired

You will need to login before you can apply for a job.

Associate Director, Portfolio and New Product Strategy

Employer
Intellia Therapeutics
Location
Cambridge, MA
Start date
Oct 30, 2024
View more categoriesView less categories

Job Details

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

How you will Achieve More with Intellia:

The Associate Director, Portfolio and New Product Strategy will be responsible for leading target- and product-level evaluations of new opportunities to inform Intellia’s portfolio strategy. You will serve as a strategic thought partner to our emerging pipeline teams (supporting early research and emerging clinical programs) and work cross-functionally with Research, Development, and Commercial colleagues. At a product level, you will develop product concepts and Target Product Profiles to guide early asset opportunity, along with identifying opportunities and barriers to long-term product success. At a portfolio level, you will consider Intellia’s long-term strategic plan in prioritizing opportunities for internal development versus externalization.

As a key leader within our emerging pipeline teams, you will be expected to:

  • Lead product-level opportunity assessments that considers the investment needs (clinical development path and resources) and longer-term opportunity (revenue potential and strategic fit)

  • Identify key areas of uncertainty and develop bespoke frameworks to allow portfolio-level comparisons across opportunities

  • Lead portfolio prioritization exercises to ensure research and development priorities are consistent with corporate plans

  • Drive market research among key stakeholders (clinicians, payers, patients) to understand opportunities and threats to our assets, along with forecasting product opportunities

  • Proactively lead and maintain competitive intelligence to develop actionable strategic insights

  • Identify and drive compelling brand strategy and value propositions that guide the goals of the program

  • Take ownership and represent the view of the Strategy team of asset opportunities at appropriate stage-gates and governance forums

About You:

This is a high visibility role within the emerging pipeline teams with influence on long-range strategy. You will be a solutions-oriented problem solver and embrace uncertainty. You will develop frameworks to support the emerging pipeline teams to enable tractable planning and problem-solving. To position yourself for success, you will be expected to have:

  • 8+ years of industry experience in portfolio strategy or New Product Planning roles with demonstrated record of progressive leadership responsibilities

  • Experience leading evaluations of novel technologies and ability to communicate effectively with a science-centric audience

  • High EQ individual that knows how to influence without authority and contribute structure to a fast-paced and often ambiguous environment

  • Demonstrated record as a change agent that respectfully challenges the ‘status quo’ to improve ways of working and decision-making

  • Strong understanding of global healthcare markets

#LI-KO2

Covid-19 Vaccination Policy:All Intellia employees, regardless of work location, are expected to follow all applicable federal, state, and local public health regulations and guidelines, and are strongly encouraged to follow all public health recommendations, including being vaccinated for COVID-19.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert